These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 16407142)
1. Peripheral cannabinoid receptor, CB2, regulates bone mass. Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142 [TBL] [Abstract][Full Text] [Related]
2. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663 [TBL] [Abstract][Full Text] [Related]
3. Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis. Sophocleous A; Marino S; Logan JG; Mollat P; Ralston SH; Idris AI J Biol Chem; 2015 Sep; 290(36):22049-60. PubMed ID: 26195631 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and the skeleton: from marijuana to reversal of bone loss. Bab I; Zimmer A; Melamed E Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular effects of growth hormone and estrogen on human bone cells. Kassem M APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492 [TBL] [Abstract][Full Text] [Related]
6. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition. Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptors and the regulation of bone mass. Bab I; Zimmer A Br J Pharmacol; 2008 Jan; 153(2):182-8. PubMed ID: 18071301 [TBL] [Abstract][Full Text] [Related]
8. Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts. Hoshino A; Ueha S; Hanada S; Imai T; Ito M; Yamamoto K; Matsushima K; Yamaguchi A; Iimura T J Cell Sci; 2013 Feb; 126(Pt 4):1032-45. PubMed ID: 23264747 [TBL] [Abstract][Full Text] [Related]
9. The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation. Sophocleous A; Landao-Bassonga E; Van't Hof RJ; Idris AI; Ralston SH Endocrinology; 2011 Jun; 152(6):2141-9. PubMed ID: 21447627 [TBL] [Abstract][Full Text] [Related]
10. Positive regulation of osteogenesis by bile acid through FXR. Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136 [TBL] [Abstract][Full Text] [Related]
11. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Idris AI; van 't Hof RJ; Greig IR; Ridge SA; Baker D; Ross RA; Ralston SH Nat Med; 2005 Jul; 11(7):774-9. PubMed ID: 15908955 [TBL] [Abstract][Full Text] [Related]
12. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Smoum R; Baraghithy S; Chourasia M; Breuer A; Mussai N; Attar-Namdar M; Kogan NM; Raphael B; Bolognini D; Cascio MG; Marini P; Pertwee RG; Shurki A; Mechoulam R; Bab I Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8774-9. PubMed ID: 26124120 [TBL] [Abstract][Full Text] [Related]
13. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
14. The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Whyte LS; Ryberg E; Sims NA; Ridge SA; Mackie K; Greasley PJ; Ross RA; Rogers MJ Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16511-6. PubMed ID: 19805329 [TBL] [Abstract][Full Text] [Related]
15. IL-1 plays an important role in the bone metabolism under physiological conditions. Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512 [TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. Shahnazari M; Dwyer D; Chu V; Asuncion F; Stolina M; Ominsky M; Kostenuik P; Halloran B Bone; 2012 Mar; 50(3):628-37. PubMed ID: 22154841 [TBL] [Abstract][Full Text] [Related]
17. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts. Gilbert LC; Chen H; Lu X; Nanes MS Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233 [TBL] [Abstract][Full Text] [Related]
18. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644 [TBL] [Abstract][Full Text] [Related]
19. Regulation of skeletal remodeling by the endocannabinoid system. Bab IA Ann N Y Acad Sci; 2007 Nov; 1116():414-22. PubMed ID: 17646266 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. Whyte LS; Ford L; Ridge SA; Cameron GA; Rogers MJ; Ross RA Br J Pharmacol; 2012 Apr; 165(8):2584-97. PubMed ID: 21649637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]